Form EFFECT Adverum Biotechnologies,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 11, 2025 |
| Accession Number: | 0001193125-25-312780 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Joy to Downtown San Francisco! Jollibee Brings Its Mouth-Watering Chickenjoy and More to the Heart of the City by the Bay
- Niber Technologies Strengthens Commercial Leadership to Accelerate Ingredient Brand Strategy
- Snappy Kraken Report Finds Financial Advisor Website Form Submissions Jumped 110% Amid AI-Driven Changes in Investor Research Behavior
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
